United Cannabis Corporation Patented Extraction Technology Featured In Cannabis Industry Journal
March 09 2018 - 2:11PM
InvestorsHub NewsWire
Denver, CO -- March 09,
2018 -- InvestorsHub NewsWire -- United Cannabis Corporation
(OTCQB:
CNAB) (the “Company” or “United Cannabis”) today announced that
it has been featured in the Cannabis
Industry Journal report, “The Ever-Growing Importance of Protecting
Cannabis Extraction Innovations” by By
Alison J. Baldwin, Brittany R. Butler, Ph.D., Nicole E.
Grimm.
The article can be read
in its entirety here.
About
United Cannabis Corporation
United Cannabis Corporation is a
biotechnology company dedicated to the development of
phyto-therapeutic based
products supported by patented technologies for the pharmaceutical,
medical, and industrial markets. The Company has long advocated the
application of cannabinoids for medical applications and is
building a platform for designing targeted therapies to increase
the quality of life for patients around the world. Most of the
Company’s products are patent protected first in class medicines
with applications to a global market. United Cannabis trades on the
OTCQB under the symbol CNAB.
For further information, please
visit www.unitedcannabis.us.
Contact:
Staff@UnitedCannabis.us
Phone:
303-386-7321
Certain statements in this news
release may contain forward-looking information within the meaning
of Rule 175 under the Securities Act of 1933, are subject to Rule
3b-6 under the Securities Exchange Act of 1934, and are subject to
the safe harbors created by those rules. All statements, other than
statements of fact, included in this release, including, without
limitation, statements regarding potential future plans and
objectives of the company, are forward-looking statements that
involve risks and uncertainties. There can be no assurance that
such statements will prove to be accurate and other results and
further events could differ materially from those anticipated in
such statements. Future events and actual results could differ
materially from those set forth in, contemplated by, or underlying
the forward-looking statements.